HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Abstract
In 1994, following work from this laboratory, it was reported that estrone-3-O-sulfamate irreversibly inhibits a new potential hormone-dependent cancer target steroid sulfatase (STS). Subsequent drug discovery projects were initiated to develop the core aryl O-sulfamate pharmacophore that, over some 20 years, have led to steroidal and nonsteroidal drugs in numerous preclinical and clinical trials, with promising results in oncology and women's health, including endometriosis. Drugs have been designed to inhibit STS, e.g., Irosustat, as innovative dual-targeting aromatase-steroid sulfatase inhibitors (DASIs) and as multitargeting agents for hormone-independent tumors, such as the steroidal STX140 and nonsteroidal counterparts, acting inter alia through microtubule disruption. The aryl sulfamate pharmacophore is highly versatile, operating via three distinct mechanisms of action, and imbues attractive pharmaceutical properties. This Perspective gives a personal view of the work leading both to the therapeutic concepts and these drugs, their current status, and how they might develop in the future.
AuthorsMark P Thomas, Barry V L Potter
JournalJournal of medicinal chemistry (J Med Chem) Vol. 58 Issue 19 Pg. 7634-58 (Oct 08 2015) ISSN: 1520-4804 [Electronic] United States
PMID25992880 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Sulfonic Acids
  • Tubulin Modulators
  • estrone-3-O-sulfamate
  • Estrone
  • irosustat
  • sulfamic acid
  • Steryl-Sulfatase
Topics
  • Animals
  • Antineoplastic Agents (chemistry, pharmacology)
  • Aromatase Inhibitors (chemistry, pharmacology, therapeutic use)
  • Breast Neoplasms (drug therapy)
  • Drug Discovery
  • Endometriosis (drug therapy)
  • Estrone (analogs & derivatives, pharmacology)
  • Female
  • Humans
  • Male
  • Molecular Targeted Therapy (methods)
  • Prostatic Neoplasms (drug therapy)
  • Steryl-Sulfatase (antagonists & inhibitors, chemistry)
  • Sulfonic Acids (chemistry, pharmacology)
  • Tubulin Modulators (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: